Cargando…
Golgi-58K can re-localize to late endosomes upon cellular uptake of PS-ASOs and facilitates endosomal release of ASOs
Phosphorothioate (PS) modified antisense oligonucleotide (ASO) drugs can trigger RNase H1 cleavage of cellular target RNAs to modulate gene expression. Internalized PS-ASOs must be released from membraned endosomal organelles, a rate limiting step that is not well understood. Recently we found that...
Autores principales: | Liang, Xue-Hai, Nichols, Joshua G, De Hoyos, Cheryl Li, Sun, Hong, Zhang, Lingdi, Crooke, Stanley T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373082/ https://www.ncbi.nlm.nih.gov/pubmed/34244781 http://dx.doi.org/10.1093/nar/gkab599 |
Ejemplares similares
-
Perinuclear positioning of endosomes can affect PS-ASO activities
por: Liang, Xue-hai, et al.
Publicado: (2021) -
Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomes
por: Liang, Xue-hai, et al.
Publicado: (2020) -
RNA modifications can affect RNase H1-mediated PS-ASO activity
por: Doxtader Lacy, Katelyn A., et al.
Publicado: (2022) -
Insights into innate immune activation via PS-ASO–protein–TLR9 interactions
por: Pollak, Adam J, et al.
Publicado: (2022) -
Some ASOs that bind in the coding region of mRNAs and induce RNase H1 cleavage can cause increases in the pre-mRNAs that may blunt total activity
por: Liang, Xue-hai, et al.
Publicado: (2020)